Editor's Note

Creating Pharma Center of Excellence in 2026 & Beyond

In 2026, the Indian pharmaceutical market is poised to grow by 7-9 percent, driven by strong domestic demand for chronic therapies and robust exports, with total revenue witnessing a significant upsurge as the country solidifies its position as a global supplier. The key drivers can be attributed towards demand in biosimilars, complex generics, and increased manufacturing of active pharmaceutical ingredients (APIs), coupled with the backing by government incentives.

If we look at APIs And Intermediates domain, custom synthesis, Drug Intermediates, and Active Pharmaceutical...  >>More